Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2022 3
2023 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
Kankasa C, Mennecier A, Sakana BLD, Molès JP, Mwiya M, Chunda-Liyoka C, D'Ottavi M, Tassembedo S, Wilfred-Tonga MM, Fao P, Rutagwera D, Matoka B, Kania D, Taofiki OA, Tylleskär T, Van de Perre P, Nagot N; PROMISE-EPI Trial Group. Kankasa C, et al. Among authors: d ottavi m. Lancet. 2024 Apr 6;403(10434):1362-1371. doi: 10.1016/S0140-6736(23)02464-9. Epub 2024 Mar 11. Lancet. 2024. PMID: 38484756 Clinical Trial.
Evaluation of the prevention of mother-to-child transmission of HIV programs at the second immunization visit in Burkina Faso and Zambia.
Tassembedo S, Mwiya M, Mennecier A, Kankasa C, Fao P, Molès JP, Kania D, Chunda-Liyoka C, Sakana BLD, D'Ottavi M, Taofiki AO, Rutagwera D, Wilfred-Tonga MM, Tylleskär T, Nagot N, Van de Perre P; PROMISE-EPI Study Group. Tassembedo S, et al. Among authors: d ottavi m. AIDS. 2024 May 1;38(6):875-885. doi: 10.1097/QAD.0000000000003827. Epub 2024 Jan 4. AIDS. 2024. PMID: 38181091 Free PMC article.
Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C.
Nagot N, D'Ottavi M, Quillet C, Debellefontaine A, Castellani J, Langendorfer N, Hanslik B, Guichard S, Baglioni R, Faucherre V, Tuaillon E, Pageaux GP, Laureillard D, Donnadieu-Rigole H. Nagot N, et al. Among authors: d ottavi m. Open Forum Infect Dis. 2022 Apr 14;9(6):ofac181. doi: 10.1093/ofid/ofac181. eCollection 2022 Jun. Open Forum Infect Dis. 2022. PMID: 35774932 Free PMC article.
Prevention of mother-to-child transmission of HIV at the second immunization visit: a cross-sectional study, Burkina Faso.
Sakana BLD, Mennecier A, Fao P, Tassembedo S, Moles JP, Kania D, Taofiki AO, Kadeba FE, Diallo I, Eymard-Duvernay S, D'Ottavi M, Meda N, Mosqueira B, Van de Perre P, Nagot N; ANRS 12388 PREVENIR-PEV Study Group. Sakana BLD, et al. Among authors: d ottavi m. Bull World Health Organ. 2022 Dec 1;100(12):769-776. doi: 10.2471/BLT.22.288522. Epub 2022 Nov 1. Bull World Health Organ. 2022. PMID: 36466198 Free PMC article.
Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIV.
Desquiret-Dumas V, D'Ottavi M, Monnin A, Goudenège D, Méda N, Vizeneux A, Kankasa C, Tylleskar T, Bris C, Procaccio V, Nagot N, Van de Perre P, Reynier P, Molès JP. Desquiret-Dumas V, et al. Among authors: d ottavi m. Biomedicines. 2022 Jul 25;10(8):1786. doi: 10.3390/biomedicines10081786. Biomedicines. 2022. PMID: 35892686 Free PMC article.
Combination of serological and cytokine release assays for improved diagnosis of childhood tuberculosis in Zambia (PROMISE-TB).
Tuaillon E, Mwyia M, Bollore K, Pisoni A, Rubbo PA, Richard M, Kremer L, Tonga MMW, Chanda D, Peries M, Vallo R, Eymard-Duvernay S, D'Ottavi M, Kankasa C, de Perre PV, Moles JP, Nagot N. Tuaillon E, et al. Among authors: d ottavi m. Int J Infect Dis. 2024 Nov;148:107248. doi: 10.1016/j.ijid.2024.107248. Epub 2024 Sep 26. Int J Infect Dis. 2024. PMID: 39341421 Free article.
An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV).
Mennecier A, Sakana BLD, D'Ottavi M, Tassembedo S, Moles JP, Kania D, Taofiki AO, Kadeba FE, Diallo I, Eymard-Duvernay S, Meda N, Mosqueira B, Fao P, Nagot N; PREVENIR-PEV Study Group; Vande Perre P. Mennecier A, et al. Among authors: d ottavi m. BMC Infect Dis. 2024 Sep 20;24(1):1014. doi: 10.1186/s12879-024-09910-z. BMC Infect Dis. 2024. PMID: 39300364 Free PMC article. Clinical Trial.
12 results